Contineum Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 2.84 M | $32.48 M | 65.19% | 10.11% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 2.45 M | $27.91 M | 100.00% | 8.71% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 2.18 M | $24.91 M | 2.72% | 7.75% |
| JOHNSON & JOHNSON | 03/18/2026 | 1.98 M | $22.62 M | 0.00% | 7.04% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 1.88 M | $21.48 M | 13.52% | 6.68% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 1.84 M | $21.06 M | 93.71% | 6.55% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 1.46 M | $16.74 M | 104.96% | 5.21% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 1.42 M | $16.24 M | 1,729.33% | 5.05% |
| VANGUARD GROUP INC | 01/29/2026 | 1.27 M | $14.53 M | 31.80% | 4.52% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 830.69 K | $9.49 M | 28.58% | 2.95% |
| COMMODORE CAPITAL LP | 02/17/2026 | 816.33 K | $9.33 M | 100.00% | 2.90% |
| FMR LLC | 02/17/2026 | 814.87 K | $9.31 M | 0.00% | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 02/09/2026 | 800.79 K | $9.15 M | 0.00% | 2.85% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 800.00 K | $9.14 M | 100.00% | 2.85% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 759.23 K | $8.68 M | 106.51% | 2.70% |
| HHLR ADVISORS, LTD. | 02/17/2026 | 669.34 K | $7.65 M | 0.00% | 2.38% |
| RED TREE MANAGEMENT, LLC | 02/11/2026 | 638.16 K | $7.29 M | 0.00% | 2.27% |
| VERSANT VENTURE MANAGEMENT, LLC | 02/12/2026 | 542.63 K | $6.20 M | 0.00% | 1.93% |
| BLACKROCK, INC. | 02/12/2026 | 536.16 K | $6.13 M | 66.49% | 1.91% |
| BOXER CAPITAL MANAGEMENT, LLC | 02/17/2026 | 494.00 K | $5.65 M | 100.00% | 1.76% |
| LONGAEVA PARTNERS L.P. | 02/17/2026 | 470.00 K | $5.37 M | 100.00% | 1.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 307.54 K | $3.52 M | 85.09% | 1.09% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 282.87 K | $3.23 M | 100.00% | 1.01% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 278.96 K | $3.19 M | 257.82% | 0.99% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 265.76 K | $3.04 M | 30.20% | 0.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 213.87 K | $2.45 M | 1.34% | 0.76% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 209.63 K | $2.40 M | 100.00% | 0.75% |
| UBS GROUP AG | 01/29/2026 | 199.39 K | $2.28 M | 191.06% | 0.71% |
| MARSHALL WACE, LLP | 02/13/2026 | 180.80 K | $2.07 M | -6.56% | 0.64% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 173.48 K | $1.98 M | 100.00% | 0.62% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 148.33 K | $1.70 M | 0.00% | 0.53% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 137.49 K | $1.57 M | 2.13% | 0.49% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 02/12/2026 | 137.43 K | $1.57 M | 100.00% | 0.49% |
| MORGAN STANLEY | 02/13/2026 | 124.29 K | $1.42 M | 33.65% | 0.44% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 110.06 K | $1.26 M | -0.11% | 0.39% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 105.59 K | $1.21 M | 250.40% | 0.38% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 91.44 K | $1.05 M | 100.00% | 0.33% |
| STATE STREET CORP | 02/13/2026 | 84.43 K | $965.01 K | 35.24% | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 72.49 K | $828.61 K | 100.00% | 0.26% |
| SAMSARA BIOCAPITAL, LLC | 02/17/2026 | 72.25 K | $825.76 K | -87.35% | 0.26% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 64.71 K | $735.00 K | 144.45% | 0.23% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 64.23 K | $734.13 K | 29,094.55% | 0.23% |
| BARCLAYS PLC | 02/13/2026 | 59.51 K | $680.17 K | 818.89% | 0.21% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 59.03 K | $674.72 K | 101.40% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 57.10 K | $652.65 K | 38.59% | 0.20% |
| NORTHERN TRUST CORP | 02/17/2026 | 53.88 K | $615.80 K | 10.03% | 0.19% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 51.03 K | $583.25 K | 100.00% | 0.18% |
| STRATEGIES WEALTH ADVISORS, LLC | 02/13/2026 | 50.00 K | $571.50 K | 0.00% | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 49.28 K | $563.27 K | 18.52% | 0.18% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 43.08 K | $492.38 K | 100.00% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Contineum Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 97 institutional investors and hedge funds held shares of Contineum Therapeutics Inc.. The most heavily invested institutionals were:
Red Tree Management, LLC: 638,158
Versant Venture Management, LLC: 542,628
UBS Group AG: 230,409
VANGUARD FIDUCIARY TRUST CO: 153,924
JANE STREET GROUP, LLC: 107,380
DIMENSIONAL FUND ADVISORS LP: 59,946
105.19% of Contineum Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 30.34 M shares in the last 24 months. This purchase volume represents approximately $410.83 M in transactions.